Abstract
Four hundred eighty-two patients undergoing single ET with GnRH-antagonist/recFSH protocol were analyzed. The incidence of premature luteinization (P above 1.5 ng/mL on the day of hCG administration) was 18.2%. Even modest rises of P in the follicular phase have detrimental effect on the implantation potential of a good-quality cleavage stage embryo. On the contrary, premature luteinization in the blastocyst subgroup had no effect on the pregnancy outcome.
MeSH terms
-
Adult
-
Chorionic Gonadotropin / administration & dosage*
-
Drug Therapy, Combination
-
Embryo Implantation
-
Embryo Transfer*
-
Female
-
Fertility Agents, Female / administration & dosage*
-
Follicle Stimulating Hormone / administration & dosage
-
Gonadotropin-Releasing Hormone / antagonists & inhibitors
-
Hormone Antagonists / administration & dosage
-
Humans
-
Luteal Phase / blood
-
Luteal Phase / drug effects*
-
Ovulation Induction / adverse effects*
-
Pregnancy
-
Pregnancy Outcome*
-
Progesterone / blood*
-
Prospective Studies
-
Recombinant Proteins / administration & dosage
-
Time Factors
-
Up-Regulation
Substances
-
Chorionic Gonadotropin
-
Fertility Agents, Female
-
Hormone Antagonists
-
Recombinant Proteins
-
Gonadotropin-Releasing Hormone
-
Progesterone
-
Follicle Stimulating Hormone